1,25-dihydroxyvitamin D(3) Ameliorates Th17 Autoimmunity Via Transcriptional Modulation of Interleukin-17A

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2011 Jul 13

PMID 21746882

Citations 195

Authors

Sneha Joshi

Luiz-Carlos Pantalena

Xikui K Liu

Sarah L Gaffen

Hong Liu

Christine Rohowsky-Kochan

Kenji Ichiyama

Akihiko Yoshimura

Lawrence Steinman

Sylvia Christakos

Sawsan Youssef

Affiliations

Soon will be listed here.

Abstract

A new class of inflammatory CD4(+) T cells that produce interleukin-17 (IL-17) (termed Th17) has been identified, which plays a critical role in numerous inflammatory conditions and autoimmune diseases. The active form of vitamin D, 1,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)], has a direct repressive effect on the expression of IL-17A in both human and mouse T cells. In vivo treatment of mice with ongoing experimental autoimmune encephalomyelitis (EAE; a mouse model of multiple sclerosis) diminishes paralysis and progression of the disease and reduces IL-17A-secreting CD4(+) T cells in the periphery and central nervous system (CNS). The mechanism of 1,25(OH)(2)D(3) repression of IL-17A expression was found to be transcriptional repression, mediated by the vitamin D receptor (VDR). Transcription assays, gel shifting, and chromatin immunoprecipitation (ChIP) assays indicate that the negative effect of 1,25(OH)(2)D(3) on IL-17A involves blocking of nuclear factor for activated T cells (NFAT), recruitment of histone deacetylase (HDAC), sequestration of Runt-related transcription factor 1 (Runx1) by 1,25(OH)(2)D(3)/VDR, and a direct effect of 1,25(OH)(2)D(3) on induction of Foxp3. Our results describe novel mechanisms and new concepts with regard to vitamin D and the immune system and suggest therapeutic targets for the control of autoimmune diseases.

Citing Articles

Does Systematic Use of Small Doses of Vitamin D Have Anti-Inflammatory Effects and Effectively Correct Deficiency Among Healthy Adults?.

Walawska-Hrycek A, Hrycek E, Galus W, Jedrzejowska-Szypulka H, Krzystanek E Nutrients. 2025; 17(2).

PMID: 39861482 PMC: 11769303. DOI: 10.3390/nu17020352.

Association between 25(OH) vitamin D and multiple sclerosis: cohort, shared genetics, and Causality.

Yu X, Lu H, Li J, Su M, Li X, Jin Y Nutr J. 2024; 23(1):151.

PMID: 39616386 PMC: 11608472. DOI: 10.1186/s12937-024-01059-4.

Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review.

Enzel D, Kriventsov M, Sataieva T, Malygina V Int J Mol Sci. 2024; 25(16).

PMID: 39201632 PMC: 11355055. DOI: 10.3390/ijms25168946.

Immunoregulatory Effects of the Active Form of Vitamin D (Calcitriol), Individually and in Combination with Curcumin, on Peripheral Blood Mononuclear Cells (PBMCs) of Multiple Sclerosis (MS) Patients.

Fasihi M, Samimi-Badabi M, Robat-Jazi B, Bitarafan S, Naser Moghadasi A, Mansouri F Antiinflamm Antiallergy Agents Med Chem. 2024; 23(2):138-147.

PMID: 38566376 DOI: 10.2174/0118715230293847240314073359.

Vitamin D in Cutaneous T-Cell Lymphoma.

Odum A, Geisler C Cells. 2024; 13(6.

PMID: 38534347 PMC: 10969440. DOI: 10.3390/cells13060503.

References

Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S . Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999; 5(2):101-4. DOI: 10.1177/135245859900500206. View

Liu X, Lin X, Gaffen S . Crucial role for nuclear factor of activated T cells in T cell receptor-mediated regulation of human interleukin-17. J Biol Chem. 2004; 279(50):52762-71. DOI: 10.1074/jbc.M405764200. View

Stark M, Huo Y, Burcin T, Morris M, Olson T, Ley K . Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity. 2005; 22(3):285-94. DOI: 10.1016/j.immuni.2005.01.011. View

Gomez-Rodriguez J, Sahu N, Handon R, Davidson T, Anderson S, Kirby M . Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase. Immunity. 2009; 31(4):587-97. PMC: 2767186. DOI: 10.1016/j.immuni.2009.07.009. View

Kim M, Fujiki R, Murayama A, Kitagawa H, Yamaoka K, Yamamoto Y . 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol Endocrinol. 2006; 21(2):334-42. DOI: 10.1210/me.2006-0231. View

Schule R, Umesono K, Mangelsdorf D, Bolado J, Pike J, Evans R . Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell. 1990; 61(3):497-504. DOI: 10.1016/0092-8674(90)90531-i. View

Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan A, Stroud J . FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell. 2006; 126(2):375-87. DOI: 10.1016/j.cell.2006.05.042. View

Axtell R, de Jong B, Boniface K, van der Voort L, Bhat R, De Sarno P . T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med. 2010; 16(4):406-12. PMC: 3042885. DOI: 10.1038/nm.2110. View

Simon K, Munger K, Yang X, Ascherio A . Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler. 2009; 16(2):133-8. PMC: 2819633. DOI: 10.1177/1352458509355069. View

10.

Correale J, Ysrraelit M, Gaitan M . Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009; 132(Pt 5):1146-60. DOI: 10.1093/brain/awp033. View

11.

Nakajima S, Hsieh J, MacDonald P, Galligan M, Haussler C, Whitfield G . The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element. Mol Endocrinol. 1994; 8(2):159-72. DOI: 10.1210/mend.8.2.8170472. View

12.

Colin E, Asmawidjaja P, van Hamburg J, Mus A, van Driel M, Hazes J . 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 2009; 62(1):132-42. DOI: 10.1002/art.25043. View

13.

Schambach F, Schupp M, Lazar M, Reiner S . Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol. 2007; 37(9):2396-9. DOI: 10.1002/eji.200737621. View

14.

Zhang F, Meng G, Strober W . Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat Immunol. 2008; 9(11):1297-306. PMC: 4778724. DOI: 10.1038/ni.1663. View

15.

Murayama A, Kim M, Yanagisawa J, Takeyama K, Kato S . Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J. 2005; 23(7):1598-608. PMC: 391066. DOI: 10.1038/sj.emboj.7600157. View

16.

Shen Q, Christakos S . The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J Biol Chem. 2005; 280(49):40589-98. DOI: 10.1074/jbc.M504166200. View

17.

Paredes R, Arriagada G, Cruzat F, Olate J, Van Wijnen A, Lian J . The Runx2 transcription factor plays a key role in the 1alpha,25-dihydroxy Vitamin D3-dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):269-71. DOI: 10.1016/j.jsbmb.2004.03.076. View

18.

Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H . Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002; 8(5):500-8. DOI: 10.1038/nm0502-500. View

19.

Park H, Li Z, Yang X, Chang S, Nurieva R, Wang Y . A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005; 6(11):1133-41. PMC: 1618871. DOI: 10.1038/ni1261. View

20.

Youssef S, Stuve O, Patarroyo J, Ruiz P, Radosevich J, Hur E . The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002; 420(6911):78-84. DOI: 10.1038/nature01158. View